Israeli artificial intelligence (AI) software developer Aidoc has received clearance from the U.S. Food and Drug Administration (FDA) for AI software that can detect and triage pulmonary embolism on pulmonary CT angiograms.
At ECR 2019, researchers from University Hospital Basel presented cases demonstrating the AI software's capacity to help manage pulmonary embolism without disrupting conventional workflows. Identifying blood flow obstructions on pulmonary CT angiograms and flagging critical exams can assist radiologists in quickly attending to time-sensitive and potentially life-threatening cases, Aidoc said.
